Cargando…

Hepatobiliary MRI: Signal intensity based assessment of liver function correlated to (13)C-Methacetin breath test

Gadoxetic acid (Gd-EOB-DTPA) is a paramagnetic MRI contrast agent with raising popularity and has been used for evaluation of imaging-based liver function in recent years. In order to verify whether liver function as determined by real-time breath analysis using the intravenous administration of (13...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haimerl, Michael, Probst, Ute, Poelsterl, Stefanie, Beyer, Lukas, Fellner, Claudia, Selgrad, Michael, Hornung, Matthias, Stroszczynski, Christian, Wiggermann, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998051/ https://www.ncbi.nlm.nih.gov/pubmed/29899400 http://dx.doi.org/10.1038/s41598-018-27401-5

Ejemplares similares

Evaluation of two-point Dixon water-fat separation for liver specific contrast-enhanced assessment of liver maximum capacity
por: Haimerl, Michael, et al.
Publicado: (2018)

Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study
por: Verloh, Niklas, et al.
Publicado: (2018)

Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry
por: Haimerl, Michael, et al.
Publicado: (2017)

Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
por: Haimerl, Michael, et al.
Publicado: (2013)

Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences
por: Verloh, Niklas, et al.
Publicado: (2018)

Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions
por: Haimerl, Michael, et al.
Publicado: (2013)

Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation
por: Verloh, Niklas, et al.
Publicado: (2015)

Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade
por: Haimerl, Michael, et al.
Publicado: (2021)

MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score
por: Haimerl, Michael, et al.
Publicado: (2014)

(13)C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

A Comparison of (13)C-Methacetin and (13)C-Octanoate Breath Test for the Evaluation of Nonalcoholic Steatohepatitis
por: Fierbinteanu-Braticevici, Carmen, et al.
Publicado: (2023)

Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases
por: Schicho, Andreas, et al.
Publicado: (2018)

Diagnostic Value of the (13)C Methacetin Breath Test in Various Stages of Chronic Liver Disease
por: Razlan, Hamizah, et al.
Publicado: (2011)

Assessment of Hepatic Detoxification Activity: Proposal of an Improved Variant of the (13)C-Methacetin Breath Test
por: Holzhütter, Hermann-Georg, et al.
Publicado: (2013)

(13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
por: Gorowska-Kowolik, Katarzyna, et al.
Publicado: (2017)

Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial
por: Beyer, Lukas P., et al.
Publicado: (2016)

Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy
por: Schicho, Andreas, et al.
Publicado: (2017)

((13)C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle
por: Molina-Molina, Emilio, et al.
Publicado: (2020)

Interpretation of non-invasive breath tests using (13)C-labeled substrates - a preliminary report with (13)C-methacetin
por: Lock, JF, et al.
Publicado: (2009)

Quantitative Evaluation of Enhancement Patterns in Focal Solid Liver Lesions with Gd-EOB-DTPA-Enhanced MRI
por: Haimerl, Michael, et al.
Publicado: (2014)

Role of (13)C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C
por: Fierbinteanu-Braticevici, Carmen, et al.
Publicado: (2014)

Effects of Ergot Alkaloids on Liver Function of Piglets as Evaluated by the (13)C-Methacetin and (13)C-α-Ketoisocaproic Acid Breath Test
por: Dänicke, Sven, et al.
Publicado: (2013)

Electrochemotherapy as a New Modality in Interventional Oncology: A Review
por: Probst, Ute, et al.
Publicado: (2018)

Navigation Systems for Treatment Planning and Execution of Percutaneous Irreversible Electroporation
por: Fuhrmann, Irene, et al.
Publicado: (2018)

Similar Complication Rates for Irreversible Electroporation and Thermal Ablation in Patients with Hepatocellular Tumors
por: Verloh, Niklas, et al.
Publicado: (2019)

Correction: Similar Complication Rates for Irreversible Electroporation and Thermal Ablation in Patients with Hepatocellular Tumors
por: Verloh, Niklas, et al.
Publicado: (2023)

Functional hepatic deterioration determined by (13)C-methacetin breath test is associated with impaired hemodynamics and late Fontan failure in adults
por: Schleiger, Anastasia, et al.
Publicado: (2022)

Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging
por: Verloh, N., et al.
Publicado: (2019)

DWI - histology: a possible means of determining degree of liver fibrosis?
por: Verloh, Niklas, et al.
Publicado: (2018)

Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis
por: Haimerl, Michael, et al.
Publicado: (2017)

Irreversible Electroporation of Malignant Hepatic Tumors - Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up
por: Dollinger, Marco, et al.
Publicado: (2015)

Correction: Irreversible Electroporation of Malignant Hepatic Tumors - Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up
por: Dollinger, Marco, et al.
Publicado: (2015)

Morphologic Alterations Precede Functional Hepatic Impairment as Determined by (13)C-Methacetin Liver Function Breath Test in Adult Fontan Patients
por: Schleiger, Anastasia, et al.
Publicado: (2021)

A continuous (13)C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
por: Lalazar, G, et al.
Publicado: (2008)

Continuous Dynamic Registration of Microvascularization of Liver Tumors with Contrast-Enhanced Ultrasound
por: Beyer, Lukas Philipp, et al.
Publicado: (2014)

Breath test using (13)C methacetin does not seem to be useful in the assessment of liver function in girls with anorexia nervosa: a case control study
por: Górowska-Kowolik, Katarzyna, et al.
Publicado: (2018)

Water–Fat Separated T1 Mapping in the Liver and Correlation to Hepatic Fat Fraction
por: Fellner, Claudia, et al.
Publicado: (2023)

Irreversible Electroporation of a Hepatocellular Carcinoma Lesion Adjacent to a Transjugular Intrahepatic Portosystemic Shunt Stent Graft
por: Niessen, Christoph, et al.
Publicado: (2013)

Porcine model for the study of liver regeneration enhanced by non-invasive (13)C-methacetin breath test (LiMAx test) and permanent portal venous access
por: Wittauer, Eva-Maria, et al.
Publicado: (2019)

Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT)
por: Bäumler, Wolf, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qs01m4mlhuthocaa5tt3np73tg